Akzo Nobel (AKZA) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Jan, 2026Executive summary
Q4 2024 organic sales grew 1% year-over-year, with flat volumes and a 1% increase in price/mix; adjusted EBITDA rose 3% to €321 million (12.3% margin), and full-year adjusted EBITDA reached €1.5 billion (14.1% margin).
Full-year organic sales increased 2%, supported by a 1% volume increase and a 130 bps expansion in adjusted gross margin.
Profit growth in Q4 was driven by Coatings, especially Marine & Protective, while Decorative Paints remained flat.
Net debt to EBITDA increased to 3x due to lower payables and accelerated restructuring, with a target to reduce leverage below 2.5x midterm.
Efficiency and transformation programs are delivering cost savings, with €170 million gross savings expected in 2025 and a total €300 million annual benefit targeted by 2027.
Financial highlights
Q4 2024 revenue was €2,619 million (up from €2,529 million in Q4 2023); adjusted EBITDA: €321 million (12.3% margin).
FY 2024 adjusted EBITDA: €1,506 million (14.1% margin); post-hyperinflation accounting: €1,478 million.
Q4 free cash flow was €284 million, impacted by timing of inventory and payables; FY 2024 free cash flow: €367 million.
Adjusted EPS for Q4 2024: €0.56 (up from €0.42); FY 2024: €3.88 (up from €3.07).
Return on investment improved to 13.3% in 2024.
Outlook and guidance
2025 adjusted EBITDA targeted above €1.55 billion, driven by €170 million in self-help savings and flat to low single-digit growth.
Leverage targeted below 2.5x net debt/adjusted EBITDA by end of 2025 and around 2x mid-term.
Midterm ambitions: adjusted EBITDA margin over 16% and ROI between 16%-19%.
No significant market rebound expected in 2025; growth to be led by Marine, Powder, and emerging Deco markets.
Guidance assumes constant currencies, organic volumes, and no major market disruptions.
Latest events from Akzo Nobel
- Flat sales, margin gains, and India divestment set stage for Axalta merger and future growth.AKZA
Q4 20253 Feb 2026 - Q2 2024 saw 2% organic sales growth, stable EBITDA, and strong Performance Coatings results.AKZA
Q2 20243 Feb 2026 - Q3 2024 delivered 1% organic growth, margin gains, and ongoing cost actions amid FX headwinds.AKZA
Q3 202419 Jan 2026 - Q1 EBITDA held at €357m as cost actions offset lower volumes; 2025 guidance reaffirmed.AKZA
Q1 202521 Dec 2025 - 2024 results, strategic focus, and governance changes approved amid active shareholder engagement.AKZA
AGM 202529 Nov 2025 - $17B all-stock merger targets $600M synergies, global scale, and industry-leading margins.AKZA
M&A Announcement18 Nov 2025 - Margins improved despite flat sales and currency headwinds, with major India divestment pending.AKZA
Q2 20254 Nov 2025 - Q3 margin rose to 15.1%, free cash flow improved, and India divestment is on track.AKZA
Q3 202522 Oct 2025